reports
- Baptiste Salaville
- Bruno Cavalier
- Roy Külter
- Steven Boumans
ORA ORANGE SA
EO FAURECIA SA
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
EN BOUYGUES SA
TNG TRANSGENE SA
SCR SCOR SE
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
VIRP VIRBAC SA
KER KERING SA
TPE PVA TEPLA AG
ISP INTESA SANPAOLO S.P.A.
01913 PRADA S.P.A.
AIXA AIXTRON SE
DLG DE'LONGHI S.P.A.
UCG UNICREDIT S.P.A.
MONC MONCLER SPA
VIG VIENNA INSURANCE GROUP AG WIENER VERSICHERUNG GRUPPE
VGP VGP NV
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
COFA COFACE SA
ALM ALMIRALL SA
ZGN ERMENEGILDO ZEGNA NV
ARYN ARYZTA AG
- Baptiste Salaville
- Bruno Cavalier
- Roy Külter
- Steven Boumans
ORA ORANGE SA
EO FAURECIA SA
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
EN BOUYGUES SA
TNG TRANSGENE SA
SCR SCOR SE
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
VIRP VIRBAC SA
KER KERING SA
TPE PVA TEPLA AG
ISP INTESA SANPAOLO S.P.A.
01913 PRADA S.P.A.
AIXA AIXTRON SE
DLG DE'LONGHI S.P.A.
UCG UNICREDIT S.P.A.
MONC MONCLER SPA
VIG VIENNA INSURANCE GROUP AG WIENER VERSICHERUNG GRUPPE
VGP VGP NV
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
COFA COFACE SA
ALM ALMIRALL SA
ZGN ERMENEGILDO ZEGNA NV
ARYN ARYZTA AG
- Christophe-Raphaël Ganet
- Christophe-Raphaël Ganet
- Luis de Toledo Heras
- Thomas Zlowodzki
- Luis de Toledo Heras
- Thomas Zlowodzki
- Christophe-Raphaël Ganet
- Christophe-Raphaël Ganet
VIRBAC Announces Third Quarter 2025 Sales
VIRBAC Announces Third Quarter 2025 Sales Sustained revenue growth at the end of September of +7.8% at constant exchange rates and scopeUpgrade of the full-year revenue guidance Revenue growth now expected to be between 5.5% and 7.5% at constant rates and scopeAdjusted recurring operating income¹ expected around 16% Press release on October 16, 2025, after market close at 5:45 p.m. CEST KEY FIGURES Revenue in first half of 2025 €1102.4M Growth at constant exchange rates and scope2 +7.8 including companion animals +11.3% farm animals +6.1% Growth at constant ...
VIRBAC annonce son chiffre d'affaires pour le troisième trimestre 2025
VIRBAC annonce son chiffre d'affaires pour le troisième trimestre 2025 Croissance soutenue du chiffre d’affaires à fin septembre de +7,8% à taux de change et périmètre constantsRelèvement des objectifs financiers annuels de chiffre d’affaires Croissance du chiffre d'affaires attendue maintenant entre 5,5% et 7,5% à taux et périmètre constants Résultat opérationnel courant ajusté1 attendu autour de 16% Communiqué diffusé le 16 octobre 2025 après bourse à 17h45 CEST CHIFFRES CLÉSChiffre d’affaires à fin septembre 20251102,4 M€Croissance à taux de change et périmètre constants2+7,8% dont an...
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction...
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies 50 mg dose of once-daily obefazimod achieved clinically meaningful improvements, across all endpoints, regardless of prior inadequate response to advanced therapies (AT-IR) 50mg dose demonstrated clinically meaningful improvements in clinical remission in particip...
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Res...
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data 50 mg once-daily dose of obefazimod led to a pooled 16.4% (p
Virbac : Declaration of the number of shares and voting rights 09/2025
Virbac : Declaration of the number of shares and voting rights 09/2025 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsSeptember, 30 20258 390 660Gross total of voting rights : 12 705 441Net total* of voting rights : 12 692...
Virbac : Déclaration d'actions et de droits de vote 09/2025
Virbac : Déclaration d'actions et de droits de vote 09/2025 DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place cotation : Euronext ParisCompartiment ACode ISIN : FR0000031577 DATENombre total d’actions composant le capital socialNombre total de droits de vote30 Septembre 20258 390 660Total brut de droits de vote : 12 705 441Total net* de droits de vote : 12 692 605 Total net* = nombre total de droits de vote attachés a...
- Maxime Kogge
- Thomas Zlowodzki
BEKB BEKAERT SA
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
SSAB A SSAB AB CLASS A
FLY SOCIETE FONCIERE LYONNAISE SA
POM PLASTIC OMNIUM SE
SZG SALZGITTER AG
KOF KAUFMAN & BROAD SA
VOE VOESTALPINE AG
ACX ACERINOX SA
TRI TRIGANO SA
ERA ERAMET SA
NDA AURUBIS AG
SESL SES-IMAGOTAG SA
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
BRAV BRAVIDA HOLDING AB
TRE TECNICAS REUNIDAS SA
RIO RIO TINTO PLC
BHP BHP GROUP LTD
AMAG AMAG AUSTRIA METALL AG
VUL VULCAN ENERGY RESOURCES
ATO ATOS SE
AAL ANGLO AMERICAN PLC
- Maxime Kogge
- Thomas Zlowodzki
BEKB BEKAERT SA
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
SSAB A SSAB AB CLASS A
FLY SOCIETE FONCIERE LYONNAISE SA
POM PLASTIC OMNIUM SE
SZG SALZGITTER AG
KOF KAUFMAN & BROAD SA
VOE VOESTALPINE AG
ACX ACERINOX SA
TRI TRIGANO SA
ERA ERAMET SA
NDA AURUBIS AG
SESL SES-IMAGOTAG SA
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
BRAV BRAVIDA HOLDING AB
TRE TECNICAS REUNIDAS SA
RIO RIO TINTO PLC
BHP BHP GROUP LTD
AMAG AMAG AUSTRIA METALL AG
VUL VULCAN ENERGY RESOURCES
ATO ATOS SE
AAL ANGLO AMERICAN PLC
- Christophe Chaput
Abivax Announces Acceptance of Additional Late-Breaking Abstract from ...
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting Abivax Announces Acceptance of AdditionalLate-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting Late Breaking Abstract titled EFFICACY AND SAFETY OF OBEFAZIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM TWO, PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 8-WEEK INDUCTION TRIALS (ABTECT-1 & 2) ...
- Maxime Kogge
PEO BANK POLSKA KASA OPIEKI SA
SDG SYNERGIE SA
INF INFOTEL SA
BEN BENETEAU SA
PKO PKO BANK POLSKI S.A.
FAGR FAGRON SA
VRAP VRANKEN-POMMERY MONOPOLE SA
GBT GUERBET SA
TRI TRIGANO SA
A1XA4J CARBIOS SA
ERA ERAMET SA
QDT QUADIENT SA
SPL SANTANDER BANK POLSKA SA
MIL BANK MILLENNIUM SA
TWEKA TKH GROUP N.V. CERT
ALR ALIOR BANK SA
RIO RIO TINTO PLC
BHP BHP GROUP LTD
VK VALLOUREC SA
ALVGO VOGO SA
ARVEN ARVERNE GROUP SA
MFEA MEDIASET NV
FERGR FERRARI GROUP PUBLIC LIMITED COMPANY
AAL ANGLO AMERICAN PLC
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.